VIVOS THERAPEUTICS, INC. (VVOS) Return on equity 2020–2024
VIVOS THERAPEUTICS, INC. (VVOS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-140.0%FY2024 · since FY2020: -71.3% → -140.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -140.0% | +3164.9 pp |
| FY2023 | -3304.9% | -2808.2 pp |
| FY2022 | -496.7% | -417.2 pp |
| FY2021 | -79.4% | -8.2 pp |
| FY2020 | -71.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VVOS financial trends
VVOS RevenueVVOS Net incomeVVOS Net marginVVOS Gross profitVVOS Gross marginVVOS Operating incomeVVOS Operating marginVVOS Operating cash flowVVOS Free cash flowVVOS Capital expendituresVVOS Stock buybacksVVOS Dividends paidVVOS Total assetsVVOS Total liabilitiesVVOS Shareholders’ equityVVOS overview →